Silver Rock Financial’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Silver Rock Financial’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-188,505	Closed	-$3.6K	–	125
2023 Q1	$3.6K	Hold	188,505	–	–	﹤0.01%	101
2022 Q4	$28.1K	Hold	188,505	–	–	0.01%	117
2022 Q3	$32K	Hold	188,505	–	–	0.01%	162
2022 Q2	$23K	Hold	188,505	–	–	0.01%	192
2022 Q1	$149K	Hold	188,505	–	–	0.03%	170
2021 Q4	$113K	Sell	188,505 -22,952	-11%	-$23.3K	0.02%	199
2021 Q3	$186K	Buy	+211,457	New	+$220K	0.03%	165

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Silver Rock Financial's PEARW Position: Q2 2023 in Review

Silver Rock Financial sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 188,505 shares — an estimated $3.6K sold.

Silver Rock Financial first reported a position in PEARW in Q3 2021 and held it in 7 quarters. The position peaked at $186K in Q3 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Silver Rock Financial reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Silver Rock Financial sold 188,505 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $3.6K.
Silver Rock Financial first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2021 and held it in 7 quarters.
Silver Rock Financial's Pear Therapeutics, Inc. Warrant position peaked at $186K in Q3 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Silver Rock Financial's 13F filing for Q2 2023, filed 14 Aug 2023.